Insurance companies deny clinical trial coverage to cancer patients for a variety of reasons. Nonresident fellow in health policy Hagop Kantarjian and Nitin Jain, assistant professor at The University of Texas MD Anderson Cancer Center, analyze the impact of limited clinical trial coverage on advancements in cancer treatment: http://bit.ly/1MeKcyR.
